Paragon Care (FRA:PXS) EBIT: €4 Mil (TTM As of Dec. 2025)


FRA:PXS Paragon Care Ltd FRA:PXS
56 GF Score
Price €0.07
GF Value €0.20
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Paragon Care EBIT?

Paragon Care FRA:PXS -6.99% 56 EBIT is €4 Mil as of Dec. 2025. GuruFocus rates FRA:PXS with a GF Score™ of 56/100 and a GF Value™ of €0.20 (Possible Value Trap). The stock has 7 warning signs investors should review.

Paragon Care's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Paragon Care's annualized ROC % for the quarter that ended in Dec. 2025 was -3.82%. Paragon Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -13.47%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Paragon Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.19%.


Paragon Care  (FRA:PXS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Paragon Care's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-23.664 * ( 1 - 32.22% )/( (384.804 + 454.479)/ 2 )
=-16.0394592/419.6415
=-3.82 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=702.017 - 325.143 - ( 11.475 - max(0, 435.454 - 427.524+11.475))
=384.804

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=740.862 - 316.713 - ( 17.514 - max(0, 471.364 - 441.034+17.514))
=454.479

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Paragon Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-17.876/( ( (42.798 + max(44.878, 0)) + (61.087 + max(116.718, 0)) )/ 2 )
=-17.876/( ( 87.676 + 177.805 )/ 2 )
=-17.876/132.7405
=-13.47 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(193.59 + 159.483 + 29.917) - (325.143 + 0 + 12.969)
=44.878

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(256.117 + 167.377 + 25.469) - (316.713 + 0 + 15.532)
=116.718

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Paragon Care's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=4.201/353.621
=1.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paragon Care EBIT Related Terms


Paragon Care EBIT Historical Data

* Premium members only.

The historical data trend for Paragon Care's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paragon Care EBIT Chart

Paragon Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.38 10.90 16.59 18.69 31.33

Paragon Care Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.04 13.62 19.49 13.14 -8.94

FRA:PXS vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Paragon Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paragon Care EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Paragon Care's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Paragon Care's EV-to-EBIT falls into.


FRA:PXS
56GF Score
Paragon Care Ltd FRA:PXS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paragon Care EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €4 Mil mean?
Paragon Care (FRA:PXS) has a EBIT of €4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Paragon Care.
Is Paragon Care's EBIT too high?
Paragon Care's current EBIT is €4 Mil. Overall, Paragon Care has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's EBIT compare to MCK and CAH?
Paragon Care's EBIT of €4 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Paragon Care. Paragon Care's current EBIT is €4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (FRA:PXS) is currently considered Possible Value Trap. The stock's GF Value™ is €0.20, compared to a current price of €0.07 — trading 66.8% below its estimated fair value. The current EBIT is €4 Mil. Paragon Care's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Paragon Care (FRA:PXS), the current EBIT is €4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paragon Care (FRA:PXS) Overvalued in 2026?

Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued. The current stock price of €0.07 is trading 66.8% below its estimated GF Value™ of €0.20. GuruFocus considers Paragon Care to be Possible Value Trap.

Key valuation signals for FRA:PXS:

  • EBIT: €4 Mil
  • GF Value™: €0.20 vs. price of €0.07 (66.8% below fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the FRA:PXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Paragon Care Business Description

Other Exchanges PGC:Australia
Address 77-97 Ricketts Road, Mount Waverley, Melbourne, VIC, AUS, 3149
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
56GF Score

Get the complete analysis for FRA:PXS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.20
GF Value